Valuation: MiniMed Group, Inc.

Market Cap 5.36B 4.66B 4.35B 4B 7.53B 511B 7.67B 51.32B 20.1B 255B 20.15B 19.7B 841B P/E 2027 *
29x
P/E 2028 * 28x
Enterprise Value 4.97B 4.32B 4.03B 3.7B 6.98B 474B 7.1B 47.56B 18.63B 236B 18.67B 18.26B 779B EV / Sales 2027 *
1.45x
EV / Sales 2028 * 1.29x
Free-Float
9.26%
Yield 2027 *
-
Yield 2028 * -
1 day+5.82%
1 week+8.09%
Current month+5.82%
1 month+22.51%
3 months+57.72%
1 week 17.66
Extreme 17.66
19.19
1 month 14.7
Extreme 14.7
19.19
Current year 10.65
Extreme 10.65
20.48
1 year 10.65
Extreme 10.65
20.48
3 years 10.65
Extreme 10.65
20.48
5 years 10.65
Extreme 10.65
20.48
10 years 10.65
Extreme 10.65
20.48
Date Insider Type Main position Quantity % Market Cap.
7/28/26 Tax

Chief Financial Officer

-23,301 0.0083%
7/28/26 Tax

Head of Human Resources

-2,099 0.0007%
7/1/26 Free

General Counsel

82,787 0.0295%
Change 5-day change 1-year change 3-year change Capi.($)
+5.82%+8.09% - - 5.07B
+0.57%+1.10%+32.92%+26.54% 12.65B
+0.97%+4.08%+26.49%+23.30% 6.78B
+0.90%+0.70%+52.30%+26.90% 5.98B
-2.88%+5.86%-21.01%+40.05% 4.75B
+0.28%+4.30%-19.66%-17.76% 4.15B
-1.78%+3.06%-26.87%+202.74% 1.84B
+3.23%-10.04%+35.34%-47.35% 1.73B
+0.49%+0.16%+59.02%-4.64% 1.58B
+0.97%+5.22%-26.50%-49.99% 1.27B
Average +0.85%+2.10%+12.45%+22.20% 4.58B
Weighted average by Cap. +0.89%+3.02%+19.62%+24.33%

Financials

2027 *2028 *
Net sales 3.42B 2.97B 2.78B 2.55B 4.81B 326B 4.89B 32.74B 12.82B 163B 12.85B 12.57B 536B 3.7B 3.22B 3B 2.76B 5.2B 353B 5.29B 35.41B 13.87B 176B 13.9B 13.59B 580B
Net income 176M 153M 143M 131M 247M 16.78B 252M 1.68B 660M 8.37B 661M 647M 27.6B 207M 180M 168M 154M 291M 19.74B 296M 1.98B 776M 9.84B 778M 761M 32.47B
Net Debt -393M -341M -319M -292M -551M -37.43B -561M -3.76B -1.47B -18.66B -1.47B -1.44B -61.56B -601M -522M -487M -447M -844M -57.26B -858M -5.75B -2.25B -28.55B -2.26B -2.21B -94.18B
Logo MiniMed Group, Inc.
MiniMed Group, Inc. is a medical technology company, which develops, manufactures, and markets a comprehensive suite of solutions for the management of diabetes. Its fully integrated system addresses pain points for people with diabetes (PWD): health outcomes and complexity of diabetes management. The MiniMed 780G is its flagship AID system. The MiniMed 780G system uses its SmartGuard dosing algorithm technology, which automatically delivers basal insulin and auto-correction doses every five minutes based on sensor glucose readings. The MiniMed 780G consists of the MiniMed 780G insulin pump, the Simplera Sync CGM sensor, and the instinct sensor. Its platform of clinically effective solutions for PWD requiring insulin therapy includes Automated Insulin Delivery (AID) Systems and a Smart Multiple Daily Injection (MDI) System. Its pipeline products are the MiniMed Flex, screenless insulin pump, next-generation Vivera dosing algorithm, and MiniMed Fit patch pump with extended wear.
Employees
-
Date Price Change Volume
26-08-03 US$19.10 +5.82% 921,664
26-07-31 US$18.05 -0.52% 613,429
26-07-30 US$18.15 -1.39% 825,076
26-07-29 US$18.40 +4.31% 1,636,072
26-07-28 US$17.64 -0.17% 1,757,519
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
19.10USD
Average target price
21.00USD
Spread / Average Target
+9.95%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. MMED Stock